Effects of Nigerian Walnut (Juglan nigra) Lectin on Haematological Parameters and Lethal Dose (LD50) on Swiss Wistar
DOI:
https://doi.org/10.54987/jemat.v9i2.645Keywords:
Juglan nigra, Nigerian walnut, Lectin, Haematological parameters, LD50Abstract
This study was designed to investigate the effects of Juglan nigra lectin on haematological parameters and lethal dose of rats. An authenticated Juglan nigra (UBHP401) collected from Lokoja was used to extract lectin and treated on Swiss Wistar rats (n=35) and (n=17) with weights from 75-129g for haematological parameters and LD50 respectively. The Wistar rats were divided into five equal groups labeled A, B, C, D, and E. Lectin concentrations were prepared and administered at stipulated days. Group A served as control, group B received 30%, C received 50%, D received 70% and group E received 90% of lectin intraperitoneally. Samples (Baseline-BL, First Harvests-FH and Second Harvest-SH) were collected from all the groups and analyzed for the following haematological parameters: white blood count (WBC), Red Blood count (RBC), Haemoglobin (HB), packed cell volume (PCV), platelet count, neutrophil, lymphocyte, monocytes, eosinophil and basophil. The data were analysed using two-way analysis of variance (ANOVA) in graph pad prism version 5.03. The Eosinophil count and white blood cell count were significantly increased P<0.005 and 0.05, whereas the HB, PCV and RBC showed significant different P<0.05 based on the day of exposure of the animal to the lectin, the platelet count was significantly increased on the basis of days of exposure of P<0.05, Eosinophil significantly increased too. Juglan nigra, (Nigerian walnut) Lectin is nontoxic as noted from LD50 result. Nigerian walnut lectin has a positive effect in haematopoietic activity of Swiss Wistar rats.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).